Clinical economics review: Gastrointestinal disease in primary care

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 3, 1996, Pages 233-239

  Jones, R H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIULCER AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST;

COLON CANCER; DRUG COST; DYSPEPSIA; ECONOMIC ASPECT; ENTERITIS; GASTROINTESTINAL DISEASE; HEALTH ECONOMICS; HELICOBACTER PYLORI; HUMAN; IRRITABLE COLON; PEPTIC ULCER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW;

GASTROINTESTINAL DISEASES; HUMANS;

EID: 0029974772     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0953-0673.1996.00233.x     Document Type: Review

References (38)

1. Jones R, ed. Gastrointestinal Problems in General Practice. Oxford: Oxford University Press, 1993.
2. Jones RH, Lydeard SE, Hobbs FDR. Dyspepsia in England and Scotland. Gut 1990; 31: 401-5.
3. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992; 304: 87-90.
4. Crosland A, Jones R. Rectal bleeding: prevalence and consultation behaviour. BMJ 1995; 311: 486-8.
5. Nyren O, Lindberg, G, Lindstrom E, et al. Economic costs of functional dyspepsia. Pharmacol Econ 1992; 1 (5): 312-24.
6. Fry J, Common Disease. Lancaster: MTP Press, 1979.
7. Department of Health. Developing NHS Purchasing and GP Fundholding: Towards a Primary Care-led NHS. London: Department of Health, 1995.
8. Jones R, Murfin D. Gastrointestinal problems in the community and in general practice. In: Jones R, ed. Gastrointestinal Problems in General Practice. Oxford : Oxford University Press, 1993.
9. Field J. Practice formularies. Practitioner 1993; 237: 586-8.
10. Department of Health. Research for Health. London: HMSO, 1992.
11. Department of Health. Research and Development Priorities in Relation to the Interface Between Primary and Secondary care: Report to the NHS Central Research and Development Committee. Leeds: NHS Executive, 1994.
12. Silen W. In: Thorn GW, Adams RD, Braunwald E, et al., eds. Peptic Ulcer in Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1991.
13. Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989; 39: 495-8.
14. Talley NJ, Weaver AL, Zinsmeister AR. Discriminant value of dyspeptic symptoms and dyspepsia subgroups in functional dyspepsia. Gastroenterology 1992; 102: A393.
15. Johannessen T, Petersen H, Kristensen P, et al. The intensity and variability of symptoms in dyspepsia. Scand J Prim Health Care 1993; ii: 50-5.
16. Gear MWL, Ormiston MC, Barnes RJ, et al. Endoscopic studies of dyspepsia in the community: an 'open access' service. BMJ 1980; 280: 1135-7.
17. British Society of Gastroenterology. Provision of Gastrointestinal Endoscopy and Related Services for a District General Hospital. London: British Society of Gastroenterology, 1990.
18. 2 receptor antagonists in patients with dyspepsia and heartburn: a cost comparison. Med J Aust 1991; 155: 20-6.
19. 2 blocker therapy or prompt endoscopy in the management of dyspepsia. Lancet 1994; 343: 811-6.
20. Lindberg G, Lindstrom E, Marke LA, et al. Gastroskopi-vid utredning av ont I magen. Stockholm: The Swedish Council of Technology Assessment, 1990.
21. Jones R. What happens to patients with non-ulcer dyspepsia after endoscopy? Practitioner 1988; 232: 75-8.
22. Hungin APS, Thomas PR, Bramble MG, et al. What happens to patients following open access gastroscopy? An outcome study from general practice. Br J Gen Pract 1994; 388: 519-21.
23. Mendall MA, Jazrawi RP, Marrero JM, et al. Serology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy. Gut 1995; 36: 330-3.
24. Patel P, Khulusi S, Mendall MA, et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet 1995; 346: 1315-8.
25. Logan RPH, Dill S, Bauer FE, et al. The European C-urea breath test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol 1991; 3:915-21.
26. Delaney BC, Kenkre JE, Hobbs FDR. A whole blood near-patient test for antibodies to Helicobacter pylori: effect on the management of dyspepsia in primary care. Fam Pract 1995; 12: 263-4.
27. Jones RH, Bosanquet N, Johnson NJ, Chong SL. Cost-effective management strategies for acid-peptic disorders. Br J Med Econ 1994; 7: 99-114.
28. Jones R. Non-ulcer dyspepsia: great expectations? Am J Gastroenterol 1995 (in press).
29. Fendrick AM, Chernew ME, Hirth RA, Bloom BS. Alternative management strategies for patients with suspected peptic ulcer disease. Am Intern Med 1995; 123: 260-8.
30. Kettell J, Jones R, Lydeard S. Reasons for consultation in irritable bowel syndrome: symptoms and patient characteristics. Br J Gen Pract 1992; 42: 459-61.
31. Farthing MJG. Irritable bowel, irritable body or irritable brain? BMJ 1995; 310: 171-5.
32. Goulston K, Dent O. Rectal bleeding: when and how to investigate. Aust Fam Physician 1987; 16: 379-82.
33. Crosland A, Jones R. Rectal bleeding: prevalence and consultation behaviour. BMJ 1995; 311: 486-8.
34. Fitjen GH, Muris JWM, Starmans R, et al. The incidence and outcome of rectal bleeding in general practice. Fam Pract 1993; 10: 283-7.
35. Donald IP, Fitzgerald Fraser JS, Wilkinson SP. Sigmoidoscopy/ proctoscopy service with open access to general practitioners. BMJ 1985; 290: 759-61.
36. Jones R. Investigating lower bowel symptoms. BMJ 1992; 304: 1521-2.
37. Barnes J, Farthing M. Rectal bleeding and lower bowel problems. In: Jones R, ed. Gastrointestinal Problems in General Practice. Oxford: Oxford University Press, 1993.
38. Atkin WS, Cuzick J, Northover JNA, et al. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993; 341: 736-40.